| Views | |
|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 100 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 1 | 1 | 8 | 9 | 4 | 13 | 3 |
| Views | |
|---|---|
| Severina_Molecular_20.pdf | 54 |
| Views | |
|---|---|
| United States | 36 |
| Germany | 6 |
| Vietnam | 4 |
| Australia | 3 |
| Canada | 3 |
| Japan | 3 |
| Brazil | 2 |
| Turkey | 2 |
| China | 1 |
| EU | 1 |
| Views | |
|---|---|
| Mountain View | 9 |
| Houston | 5 |
| Fairfield | 3 |
| Hanoi | 3 |
| Ottawa | 3 |
| Baltimore | 2 |
| Dearborn | 2 |
| Mulgrave | 2 |
| Palo Alto | 2 |
| White Plains | 2 |